<DOC>
	<DOC>NCT01169727</DOC>
	<brief_summary>The purpose of this study is to evaluate health status of uncontrolled Chronic Obstructive Pulmonary Disease (COPD) patients in response to treatments in clinical practice.</brief_summary>
	<brief_title>Observational Study to Evaluate Health Status of Chronic Obstructive Pulmonary Disease (COPD) Patients in Response to Real-life Treatments in Thailand</brief_title>
	<detailed_description>MC MD</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<criteria>1. Provision of informed consent prior to any study specific procedures 2. Male or nonpregnant female aged &gt;40 years 3. A clinical diagnosis of COPD with FEV1/ FVC &lt;0.70 and require combination or modified therapy 4. Smoke &gt; 10 Pack Year 1. Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site) 2. Participation in a clinical study (precluding noninterventional study or registry) during the last 3 months</criteria>
	<gender>All</gender>
	<minimum_age>41 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>COPD and CCQ score</keyword>
	<keyword>Changes in PEF,overall CCQ score</keyword>
</DOC>